Classical Hodgkin Lymphoma: From Past to Future—A Comprehensive Review of Pathophysiology and Therapeutic Advances F Munir, V Hardit, IN Sheikh, S AlQahtani, J He, B Cuglievan, C Hosing, ... International journal of molecular sciences 24 (12), 10095, 2023 | 30 | 2023 |
Venetoclax for acute myeloid leukemia in pediatric patients: a Texas Medical Center experience A Trabal, A Gibson, J He, D McCall, M Roth, C Nuñez, M Garcia, ... Cancers 15 (7), 1983, 2023 | 25 | 2023 |
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies B Cuglievan, J Connors, J He, S Khazal, S Yedururi, J Dai, S Garces, ... Leukemia 37 (9), 1767-1778, 2023 | 22 | 2023 |
Combining CAR T cell therapy and oncolytic Virotherapy for pediatric solid tumors: a promising option J He, F Munir, D Ragoonanan, W Zaky, SJ Khazal, P Tewari, J Fueyo, ... Immuno 3 (1), 37-56, 2023 | 13 | 2023 |
Translational advances in the treatment of childhood acute lymphoblastic leukemia: narrative review of current and emerging molecular and immunotherapies F Munir, J He, J Connors, M Garcia, A Gibson, D McCall, C Nunez, ... Translational Pediatrics 12 (3), 487, 2023 | 6 | 2023 |
Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia J He, F Munir, S Catueno, JS Connors, A Gibson, L Robusto, D McCall, ... Cancers 16 (5), 858, 2024 | 3 | 2024 |
Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm J He, MB Garcia, JS Connors, CA Nuñez, AE Quesada, A Gibson, M Roth, ... Journal of Pediatric Hematology/Oncology 45 (8), e1001-e1004, 2023 | 3 | 2023 |
The emerging field of viroimmunotherapy for pediatric brain tumors M Garcia-Moure, V Laspidea, S Gupta, AG Gillard, S Khatua, ... Neuro-oncology 26 (11), 1981-1993, 2024 | 1 | 2024 |
Increased Neonatal Mortality and Increasing Rate of Cerebral Venous Sinus Thrombosis in Hospitalized Children: A Pediatric Health Information System Database Study J He, NA Montanez, S Fraser, A Barnett, C Silos, K Smith, LV Srivaths Blood 142, 133, 2023 | 1 | 2023 |
Adjuvant therapy with oncolytic adenovirus Delta-24-RGDOX after intratumoral adoptive T-cell therapy promotes antigen spread to sustain systemic antitumor immunity H Jiang, DH Shin, Y Yi, X Fan, J Gumin, J He, AG Gillard, FF Lang, ... Cancer Research Communications 3 (6), 1118-1131, 2023 | 1 | 2023 |
Immunotherapy-Related Neurotoxicity in the Central Nervous System of Children with Cancer J He, J Connors, A Meador, S Xu, H Meador, H Jiang, J Fueyo, ... Neuro-Oncology, noae243, 2024 | | 2024 |
EXTH-21. WINNING THE TUG OF WAR BETWEEN VIRUS AND TUMOR IMMUNODOMINANCE IN GLIOMAS TREATED WITH ONCOLYTIC ADENOVIRUSES USING TOLEROGENIC STRATEGIES D Ho Shin, B Ozpolat, A Gillard, M Garcia-Moure, H Jiang, A Lopez-Rivas, ... Neuro-Oncology 26 (Supplement_8), viii241-viii241, 2024 | | 2024 |
EXTH-34. ACETYLATION SUPPRESSION MEETS ONCOLYTIC VIRUSES FOR THE TREATMENT OF PEDIATRIC DIFFUSE MIDLINE GLIOMA A Parthasarathy, MG Moure, J He, A Gillard, A Paparella, DH Shin, ... Neuro-Oncology 26 (Supplement_8), viii244-viii244, 2024 | | 2024 |
IMMU-48. CRACKING THE ROLE OF ONCOMETABOLITES IN VIROIMMUNOTHERAPY FOR PEDIATRIC MALIGNANT BRAIN TUMORS MG Moure, AR Lopez-Rivas, A Parthasarathy, DH Shin, H Jiang, J He, ... Neuro-Oncology 26 (Supplement_8), viii163-viii163, 2024 | | 2024 |
Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia A Gibson, S Dickson, D McCall, M Garcia, J Connors, J He, M Roth, ... Pediatric Blood & Cancer, e31286, 2024 | | 2024 |
733 Antitumor activity of CAR T cells potentiated by oncolytic adenoviruses armed with immune stimulators H Jiang, J He, A Duran, X Fan, DH Shin, A Parthasarathy, AG Gillard, ... Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024 | | 2024 |
1001 Targeting the immunometabolic factor AhR boosts glioma viroimmunotherapy AR Lopez-Rivas, AG Gillard, A Parthasarathy, DH Shin, MG Moure, ... Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024 | | 2024 |
774 Refocusing on tumors: overcoming antiviral immunity in oncolytic virotherapy DH Shin, B Ozpolat, AG Gillard, MG Moure, H Jiang, A Lopez-Rivas, ... Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024 | | 2024 |
997 Unlocking the therapeutic potential of glioma virotherapy: NONO and cGAMP as key regulators of innate immune activation AG Gillard, DH Shin, V Laspidea, SK Singh, LA Hampton, H Jiang, X Fan, ... Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024 | | 2024 |
827 Viroimmunotherapy combined with acetylation suppression: advanced therapeutics for pediatric diffuse midline gliomas A Parthasarathy, MG Moure, J He, AG Gillard, A Paparella, DH Shin, ... Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024 | | 2024 |